Evidence map›Paper›PMID 24466061›Full record

ArticlePloS one2014

Endocytosis of Fgf8 is a double-stage process and regulates spreading and signaling.

Charanya Rengarajan, Alexandra Matzke, Luisa Reiner, Véronique Orian-Rousseau, Steffen Scholpp

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Control of signaling molecule range during developmental patterning.Cellular and molecular life sciences : CMLS · 2017
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charanya RengarajanKarlsruhe Institute of Technology (KIT), Institute of Toxicology and Genetic (ITG), Karlsruhe, Germany.
Alexandra MatzkeKarlsruhe Institute of Technology (KIT), Institute of Toxicology and Genetic (ITG), Karlsruhe, Germany.
Luisa ReinerKarlsruhe Institute of Technology (KIT), Institute of Toxicology and Genetic (ITG), Karlsruhe, Germany.
Véronique Orian-RousseauKarlsruhe Institute of Technology (KIT), Institute of Toxicology and Genetic (ITG), Karlsruhe, Germany.
Steffen ScholppKarlsruhe Institute of Technology (KIT), Institute of Toxicology and Genetic (ITG), Karlsruhe, Germany.
Karlsruhe Institute of Technology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tightly controlled concentration gradients of morphogens provide positional information and thus regulate tissue differentiation and morphogenesis in multicellular organisms. However, how such morphogenetic fields are formed and maintained remains debated. Here we show that fibroblast growth factor 8 (Fgf8) morphogen gradients in zebrafish embryos are established and maintained by two essential mechanisms. Firstly, Fgf8 is taken up into the cell by clathrin-mediated endocytosis. The speed of the uptake rate defines the range of the morphogenetic gradient of Fgf8. Secondly, our data demonstrate that after endocytosis the routing of Fgf8 from the early endosome to the late endosome shuts down signaling. Therefore, intracellular endocytic transport regulates the intensity and duration of Fgf8 signaling. We show that internalization of Fgf8 into the early endosome and subsequent transport towards the late endosome are two independent processes. Therefore, we hypothesize that Fgf8 receiving cells control both, the propagation width and the signal strength of the morphogen.

Indexed as

EndocytosisSignal TransductionAnimalsClathrinEmbryo, NonmammalianEndosomesFibroblast Growth Factor 8HEK293 CellsHSP70 Heat-Shock ProteinsHumansProtein TransportZebrafishZebrafish ProteinsClathrinFibroblast Growth Factor 8HSP70 Heat-Shock ProteinsZebrafish Proteins

Identifiers

PMID24466061
PMCPMC3896487
OpenAlexW2322642516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.